R a d i o l o g i s t U s e s F l y w h e e l t o A c c e l e r a t e M a j o r C O V I D - 1 9 A I R e a d e r S t u d y a n d D i s c o v e r D i a g n o s t i c I m a g i n g P a t t e r n s I d e n t i f y i n g a r a d i o l o g y p l a t f o r m t o m a n a g e m u l t i - s i t e C T b i o m a r k e r s t u d y During the initial sur ge of CO VID-19 cases in the U .S. in Mar ch 2020, car diothor acic r adiologist K athr yn Olsen, M.D ., w as dishear tened after hearing fr om colleagues that the PCR test used as the gold standar d to detect the virus had a sensitivity r ate of only 70%. With early diagnosis critical to mitigating morbidities and community spr ead, and giv en the clinical utility and wide use of computeriz ed tomogr aphy (C T), she turned to imaging biomark ers. De

Join for free to read